Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin and Zoledronic Acid for Hutchinson-Gilford Progeria Syndrome
NCT00731016Phase 2Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Oct 2008
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pravastatin, zoledronic acid in Hutchinson-Gilford progeria syndrome (HGPS), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Oct 2008; status: completed.
02
Drugs
pravastatinzoledronic acid
03
Conditions
Hutchinson-Gilford progeria syndrome (HGPS)
Beyond the preview
Go deeper on NCT00731016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731016.